FDA guidance highlights E&L considerations for ophthalmic drug products
In draft guidance on quality considerations for topical ophthalmic drug products, the US Food and Drug Administration (FDA) provided recommendations for E&L testing.
List view / Grid view
In draft guidance on quality considerations for topical ophthalmic drug products, the US Food and Drug Administration (FDA) provided recommendations for E&L testing.
Innovative technologies were identified as potential solutions for enhancing bioavailability in ocular drug delivery in a research review.
Using AI and machine learning techniques, researchers have developed a new computational tool to screen patients with common retinal diseases, potentially speeding diagnoses and treatment...